Vicarious Surgical (RBOT) S-4/A 15 Jul 21 Registration of securities issued in business combination transactions (amended) Financial data

Document And Entity Information

Document And Entity Information	3 Months Ended
	Mar. 31, 2021
Document Information Line Items
Entity Registrant Name	D8 Holdings Corp.
Document Type	S-4/A
Amendment Flag	true
Amendment Description	Amendment No. 1
Entity Central Index Key	0001812173
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Incorporation, State or Country Code	E9

Condensed Balance Sheets

Condensed Balance Sheets - USD ($)	Mar. 31, 2021	Dec. 31, 2020
Current assets:
Cash	$ 1,027,964	$ 1,097,313
Prepaid expenses	65,000	132,958
Total current assets	1,092,964	1,230,271
Investments held in Trust Accounts	345,258,401	345,191,130
Total Assets	346,351,365	346,421,401
Current liabilities:
Accounts payable	57,199	13,682
Accrued expenses	1,457,512	112,538
Total current liabilities	1,514,711	126,220
Deferred underwriting commissions	12,075,000	12,075,000
Warrant liabilities	31,140,500	29,415,500
Total liabilities	44,730,211	41,616,720
Commitments and Contingencies (Note 5)
Class A ordinary shares, $0.0001 par value; 200,000,000 shares authorized, 29,662,115 and 29,980,468 shares subject to possible redemption at $10.00 per share as of March 31, 2021 and December 31, 2020, respectively	296,621,150	299,804,680
Shareholders’ Equity:
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
Class A ordinary shares, $0.0001 par value; 200,000,000 shares authorized; 4,837,885 and 4,519,532 shares issued and outstanding (excluding 29,662,115 and 29,980,468 shares subject to possible redemption) as of March 31, 2021 and December 31, 2020, respectively	484	452
Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 8,625,000 shares issued and outstanding as of March 31, 2021 and December 31, 2020	863	863
Additional paid-in capital	17,644,892	14,461,394
Accumulated deficit	(12,646,235)	(9,462,708)
Total shareholders’ equity	5,000,004	5,000,001
Total Liabilities and Shareholders’ Equity	$ 346,351,365	$ 346,421,401

Condensed Balance Sheets (Paren

Condensed Balance Sheets (Parentheticals) - $ / shares	Mar. 31, 2021	Dec. 31, 2020
Preference shares, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Preference shares, shares authorized	1,000,000	1,000,000
Preference shares, shares issued	0	0
Preference shares, shares outstanding	0	0
Class A ordinary shares
Ordinary shares, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Ordinary shares, authorized	200,000,000	200,000,000
Ordinary shares, subject to possible redemption	29,662,115	29,980,468
Ordinary shares, subject to possible redemption, per share (in Dollars per share)	$ 10	$ 10
Ordinary shares, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Ordinary shares, shares authorized	200,000,000	200,000,000
Ordinary shares, shares issued	4,837,885	4,519,532
Ordinary shares, shares outstanding	4,837,885	4,519,532
Class B ordinary shares
Ordinary shares, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Ordinary shares, shares authorized	20,000,000	20,000,000
Ordinary shares, shares issued	8,625,000	8,625,000
Ordinary shares, shares outstanding	8,625,000	8,625,000

Unaudited Condensed Statement o

Unaudited Condensed Statement of Operations - USD ($)	3 Months Ended	8 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Operating expenses
General and administrative expenses	$ 1,495,798	$ 297,469
General and administrative – related party		54,839
Administrative fee – related party	30,000
Loss from Operations	(1,525,798)	(352,308)
Change in fair value of warrant liabilities	(1,725,000)	(8,613,000)
Financing cost – derivative warrant liabilities		(688,530)
Net gain from investments held in Trust Accounts	67,271	191,130
Net loss	(3,183,527)	(9,462,708)
Class A ordinary shares
Operating expenses
Net loss
Weighted average shares outstanding of basic and diluted (in Shares)	34,500,000	34,312,500
Basic and diluted net income per share (in Dollars per share)	$ 0	$ 0.01
Class B ordinary shares
Operating expenses
Net loss
Weighted average shares outstanding of basic and diluted (in Shares)	8,625,000	8,280,711
Basic and diluted net income per share (in Dollars per share)	$ (0.38)	$ (1.17)

Unaudited Condensed Statement_2

Unaudited Condensed Statement of Changes in Shareholders' Equity - USD ($)	Class A ordinary shares	Class B ordinary shares	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at May. 05, 2020
Balance (in Shares) at May. 05, 2020
Issuance of Class B ordinary shares to Sponsor		$ 863	24,137		25,000
Issuance of Class B ordinary shares to Sponsor (in Shares)		8,625,000
Sale of units in initial public offering, less fair value of public warrants	$ 3,450		333,094,050		333,097,500
Sale of units in initial public offering, less fair value of public warrants (in Shares)	34,500,000
Offering costs			(18,855,111)		(18,855,111)
Shares subject to possible redemption	$ (2,998)		(299,801,682)		(299,804,680)
Shares subject to possible redemption (in Shares)	(29,980,468)
Net loss				(9,462,708)	(9,462,708)
Balance at Dec. 31, 2020	$ 452	$ 863	14,461,394	(9,462,708)	5,000,001
Balance (in Shares) at Dec. 31, 2020	4,519,532	8,625,000
Shares subject to possible redemption	$ 32		3,183,498		3,183,530
Shares subject to possible redemption (in Shares)	318,353
Net loss				(3,183,527)	(3,183,527)
Balance at Mar. 31, 2021	$ 484	$ 863	$ 17,644,892	$ (12,646,235)	$ 5,000,004
Balance (in Shares) at Mar. 31, 2021	4,837,885	8,625,000

Unaudited Condensed Statement_3

Unaudited Condensed Statement of Cash Flows - USD ($)	3 Months Ended	8 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Cash Flows from Operating Activities:
Net loss	$ (3,183,527)	$ (9,462,708)
Adjustments to reconcile net loss to net cash used in operating activities:
General and administrative expenses paid by related parties		16,745
Change in fair value of warrant liabilities	1,725,000	8,613,000
Financing cost – derivative warrant liabilities		688,530
Net gain from investments held in Trust Accounts	(67,271)	(191,130)
Changes in operating assets and liabilities:
Prepaid expenses	67,958	(132,958)
Accounts payable	43,517	13,682
Accrued expenses	1,344,974	27,538
Net cash used in operating activities	(69,349)	(427,301)
Cash Flows from Investing Activities
Principal deposited in Trust Accounts		(345,000,000)
Net cash used in investing activities		(345,000,000)
Cash Flows from Financing Activities:
Repayment of note payable and advances to related party		(126,762)
Proceeds received from initial public offering, gross		345,000,000
Proceeds from private placement		8,900,000
Payment of offering costs		(7,248,624)
Net cash provided by financing activities		346,524,614
Net change in cash	(69,349)	1,097,313
Cash – beginning of the period	1,097,313
Cash – end of the period	1,027,964	1,097,313
Supplemental disclosure of noncash activities:
Offering costs paid in exchange for issuance of Class B ordinary shares to Sponsor		25,000
Offering costs included in accrued expenses		85,000
Offering costs included in note payable		110,017
Deferred underwriting commissions in connection with the initial public offering		12,075,000
Initial value of Class A ordinary shares subject to possible redemption		267,561,360
Change in value of Class A ordinary shares subject to possible redemption	$ 3,183,530	$ 32,243,320

Description of Organization and

Description of Organization and Business Operations	3 Months Ended	8 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Description of Organization and Business Operations [Abstract]
Description of Organization and Business Operations	Note 1 — Description of Organization and Business Operations D8 Holdings Corp. (the “Company”) was incorporated as a Cayman Islands exempted company on May As of March -operating Financing The Company’s sponsor is D8 Sponsor LLC, a Cayman Islands limited liability company (the “Sponsor”). The registration statement for the Initial Public Offering was declared effective on July -half -allotment -Allotment Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 8,000,000 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”) to the Sponsor, each exercisable to purchase one Class A ordinary share at $11.50 per share, at a price of $1.00 per Private Placement Warrant, generating gross proceeds to the Company of $8.0 -Allotment Trust Account Upon the closing of the Initial Public Offering and the Private Placement, $345.0 -7 Initial Business Combination The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete an initial Business Combination with one or more operating businesses or assets with a fair market value of at least 80% of the net assets held in the Trust Account (as defined below) (excluding the amount of any deferred underwriting discount held in the Trust Account) at the time of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post -transaction The Company will provide its holders (the “Public Shareholders”) of its Class A ordinary shares, par value $0.0001, sold in the Initial Public Offering, with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a general meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per Public Share). The per -share Notwithstanding the foregoing, the Amended and Restated Memorandum and Articles of Association provide that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 20% or more of the Class A ordinary shares sold in the Initial Public Offering, without the prior consent of the Company. The Company’s Sponsor, officers and directors (the “initial shareholders”) have agreed, pursuant to a written agreement with the Company, that they will not propose any amendment to the Amended and Restated Memorandum and Articles of Association (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the initial Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination within 24 -initial -share If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per -share The initial shareholders have agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the initial shareholders or members of the Company’s management team acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 5) held in the Trust Account in the event the Company does not complete a Business Combination within in the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.00 per share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or business combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the trust account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable. This liability will not apply with respect to any claims by a third party who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) or to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third -party Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non -emerging This may make the comparison of the Company’s financial statement with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Liquidity and Capital Resources As of March Prior to the completion of the Initial Public Offering, the Over -Allotment -Allotment Based on the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity from the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors to meet its needs through the earlier of the consummation of a Business Combination or one year from this filing. Over this time period, the Company will be using these funds for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination.	NOTE 1. DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND BASIS OF PRESENTATION Organization and General D8 Holdings Corp. (the “Company”) is a blank check company incorporated in the Cayman Islands on May At December -operating Financing The Company’s sponsor is D8 Sponsor LLC, a Cayman Islands limited liability company (“Sponsor”). The registration statement for the Initial Public Offering was declared effective on July -half -allotment -Allotment Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 8,000,000 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”) to the Sponsor, each exercisable to purchase one Class A ordinary share at $11.50 per share, at a price of $1.00 per Private Placement Warrant, generating gross proceeds to the Company of $8.0 -Allotment Trust Account Upon the closing of the Initial Public Offering and the Private Placement, $345.0 -7 Initial Business Combination The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete an initial Business Combination with one or more operating businesses or assets with a fair market value of at least 80% of the net assets held in the Trust Account (as defined below) (excluding the amount of any deferred underwriting discount held in the Trust Account) at the time of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post -transaction The Company will provide its holders (the “Public Shareholders”) of its Class A ordinary shares, par value $0.0001, sold in the Initial Public Offering, with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a general meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per Public Share). The per -share Notwithstanding the foregoing, the Amended and Restated Memorandum and Articles of Association provide that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 20% or more of the Class A ordinary shares sold in the Initial Public Offering, without the prior consent of the Company. The Company’s Sponsor, officers and directors (the “initial shareholders”) have agreed, pursuant to a written agreement with the Company, that they will not propose any amendment to the Amended and Restated Memorandum and Articles of Association (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the initial Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination within 24 “Combination Period”) or (B) with respect to any other material provisions relating to shareholders’ rights or pre -initial -share If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per -share In connection with the redemption of 100% of the Company’s outstanding Public Shares for a portion of the funds held in the Trust Account, each holder will receive a full pro rata portion of the amount then in the Trust Account, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay the Company’s taxes payable (less taxes payable and up to $100,000 of interest to pay dissolution expenses). The initial shareholders have agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the initial shareholders or members of the Company’s management team acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to its deferred underwriting commission (see Note 5) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.00 per share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or business combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the trust account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable. This liability will not apply with respect to any claims by a third party who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) or to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third -party Liquidity and Capital Resources As of December Prior to the completion of the Initial Public Offering, the Over -Allotment -Allotment Based on the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity from the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors to meet its needs through the earlier of the consummation of a Business Combination or one year from this filing. Over this time period, the Company will be using these funds for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination.

Basic of Presentation and Summa

Basic of Presentation and Summary of Significant Accounting Policies	3 Months Ended	8 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Accounting Policies [Abstract]
Basic of Presentation and Summary of Significant Accounting Policies	Note 2 — Basic of Presentation and Summary of Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed financial statements of the Company have been prepared in accordance with United States generally accepted accounting principles (“U.S. GAAP”) for interim financial information and Article 8 of Regulation S -X The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Company’s Annual Report on Form 10K/A filed with the SEC on May Emerging Growth Company As an emerging growth company, the Company may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes -Oxley Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non -emerging opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. This may make comparison of the Company’s financial statement with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liability. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short -term Investments Held in Trust Accounts The Company’s portfolio of investments is comprised solely of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities, or a combination thereof. The Company’s investments held in the Trust Accounts are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in gain on investment (net), dividends and interest held in Trust Account in the accompanying unaudited condensed statement of operations. The estimated fair values of investments held in the Trust Accounts are determined using available market information. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000, and investments held in Trust Accounts. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. Fair Value of Financial Instruments Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three -tier The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: • • • In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. As of March -term Offering Costs Associated with the Initial Public Offering The Company complies with the requirements of the FASB ASC Topic 340 -10-S99-1 -in Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at March Income Taxes FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of March penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of March The Company is considered an exempted Cayman Islands company and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the periods presented. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. Net Income (Loss) per Ordinary Share The Company complies with accounting and disclosure requirements of ASC Topic 260, “Earnings Per Share.” Net income (loss) per ordinary share is computed by dividing net income (loss) by the weighted average number of ordinary shares outstanding during the period. The Company has not considered the effect of the warrants sold in the Initial Public Offering and Private Placement to purchase an aggregate of 26,150,000 -dilutive The Company’s statement of operations include a presentation of income per share for ordinary shares subject to redemption in a manner similar to the two -class Derivative warrant liabilities The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued shares purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815 -15 -assessed The Company accounts for its 26,150,000 warrants issued in connection with its Initial Public Offering (17,250,000) and Private Placement (8,900,000) as derivative warrant liabilities in accordance with ASC 815 -40 -measurement -Scholes -Scholes Recent Adopted Accounting Standards In August 2020, the FASB issued ASU No. 2020 -06 -20 -40 -06 -linked and it simplifies the diluted earnings per share calculation in certain areas. The Company adopted ASU 2020 -06 Recent Issued Accounting Standards The Company’s management does not believe that any recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the accompanying financial statement.	NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of presentation The accompanying financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC. As described in Note 2 — Restatement of Previously Issued Financial Statements and Note 11 — Quarterly Financial Information (unaudited), the Company’s financial statements for the period from May -K Emerging growth company As an emerging growth company, the Company may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes -Oxley Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non -emerging Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. This may make comparison of the Company’s financial statement with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Concentrations of credit risk Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage of $250,000, and investments held in Trust Account. At December Investments Held in the Trust Account The Company’s portfolio of investments held in the Trust Account is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, investments in money market funds that invest in U.S. government securities, cash, or a combination thereof. The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in gain on Investments Held in Trust Account in the accompanying statement of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. Fair Value of Financial Instruments Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three -tier • • • In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. As of December -term The fair value of Public Warrants, was calculated using a binomial / lattice model that assumes optimal exercise of the Company’s redemption option, including the make whole table, at the earliest possible date. The fair value of Private Warrants was calculated using the Black -Scholes Use of estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liability. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short -term Offering costs Offering costs consist legal, accounting, underwriting fees and other costs incurred in connection with the formation and preparation for the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities are expensed as incurred, presented as non -operating Class A Ordinary Shares subject to possible redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Shares of Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Shares of conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, shares of Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at December Derivative Warrant liabilities The Company does not use derivative instruments to hedge its exposures to cash flow, market or foreign currency risks. Management evaluates all of the Company’s financial instruments, including issued Warrants to purchase its Class A ordinary shares, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815 -15 -assessed The Company issued 17,250,000 Warrants to purchase Class A ordinary shares to investors in the Company’s Initial Public Offering and simultaneously issued 8,900,000 Private Placement Warrants. All of the Company’s outstanding Warrants are recognized as derivative liabilities in accordance with ASC 815 -40 -measurement -Scholes Net loss per ordinary share The Company complies with accounting and disclosure requirements of ASC Topic 260, “Earnings Per Share.” Net loss per ordinary share is computed by dividing net loss by the weighted average number of ordinary shares outstanding during the period. The Company has not considered the effect of the Warrants sold in the Initial Public Offering and Private Placement to purchase an aggregate of 26,150,000 -dilutive The Company’s statement of operations include a presentation of income per share for ordinary shares subject to redemption in a manner similar to the two -class Income taxes ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more -likely-than-not The Company is considered an exempted Cayman Islands company and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the periods presented. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. Recent accounting pronouncements In August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020 -06 Debt — debt with Conversion and Other Options (Subtopic 470 -20 ) and Derivatives and Hedging — Contracts in Entity’ Own Equity (Subt opic 815 -40 ): Accounting for Convertible Instruments and Contracts in an Entity’ Own Equity -06 -linked -06 The Company’s management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.

Initial Public Offering

Initial Public Offering	3 Months Ended	8 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Initial Public Offering [Abstract]
INITIAL PUBLIC OFFERING	Note 3 — Initial Public Offering On July -allotment -Allotment Each Unit consists of one Class A ordinary share, par value $0.0001 and one -half	NOTE 4. INITIAL PUBLIC OFFERING On July -allotment -Allotment Each Unit consists of one Class A ordinary share, par value $0.0001 and one -half

Related Party Transactions

Related Party Transactions	3 Months Ended	8 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Related Party Transactions [Abstract]
Related Party Transactions	Note 4 — Related Party Transactions Founder Shares On May -allotment -allotment The initial shareholders agreed, subject to limited exceptions, not to transfer, assign or sell any of their Founder Shares and any Class A ordinary shares issuable upon conversion thereof until the earlier to occur of: (i) one year after the completion of the initial Business Combination, or (ii) the date on which the Company completes a liquidation, merger, share exchange or other similar transaction after the initial Business Combination that results in all of the Company’s shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property; except to certain permitted transferees and under certain circumstances (the “lock -up -divisions -trading -up Private Placement Warrants On July ordinary share at $11.50 per share, at a price of $1.00 per Private Placement Warrant, generating gross proceeds to the Company of $8.0 -Allotment Each warrant is exercisable to purchase one Class A ordinary share at $11.50 per share. A portion of the proceeds from the Private Placement Warrants were added to the proceeds from the Initial Public Offering held in the Trust Accounts. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Insiders agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the initial Business Combination. Sponsor Loan On May Working Capital Loans In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Accounts to repay the Working Capital Loans but no proceeds held in the Trust Accounts would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination or, at the lender’s discretion, up to $1.5 Administrative Services Agreement Commencing on the date of the final prospectus, the Company has agreed to pay the Sponsor a total of $10,000 per month for office space, utilities, secretarial and administrative support services. Upon completion of the Initial Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees. For the three months ended March	NOTE 5. RELATED PARTY TRANSACTIONS Founder Shares On May -allotment -allotment The initial shareholders agreed, subject to limited exceptions, not to transfer, assign or sell any of their Founder Shares and any Class A ordinary shares issuable upon conversion thereof until the earlier to occur of: (i) one year after the completion of the initial Business Combination, or (ii) the date on which the Company completes a liquidation, merger, share exchange or other similar transaction after the initial Business Combination that results in all of the Company’s shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property; except to certain permitted transferees and under certain circumstances (the “lock -up the foregoing, if (1) the closing price of Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub -divisions -trading -up Private Placement Warrants On July -Allotment Each Warrant is exercisable to purchase one Class A ordinary share at $11.50 per share. A portion of the proceeds from the Private Placement Warrants were added to the proceeds from the Initial Public Offering held in the Trust Accounts. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Insiders agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the initial Business Combination. Sponsor Loan On May Working Capital Loans In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Accounts to repay the Working Capital Loans but no proceeds held in the Trust Accounts would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination or, at the lender’s discretion, up to $1.5 Administrative Support Agreement Commencing on the date of the final prospectus, the Company has agreed to pay the Sponsor a total of $10,000 per month for office space, utilities, secretarial and administrative support services. The Company incurred and paid approximately $55,000 in these fees for the period from the effective date of the Initial Public Offering through December

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended	8 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 5 — Commitments and Contingencies Registration Rights The holders of Founder Shares, Private Placement Warrants, and securities that may be issued upon conversion of Working Capital Loans, if any, will be entitled to registration rights pursuant to a registration rights agreement dated as of July -up Underwriting Agreement The Company granted the underwriters a 45 -day -allotments -allotment The underwriters were paid a cash underwriting discount of $0.20 per unit, or $6.9 Risks and Uncertainties Management continues to evaluate the impact of the COVID -19	NOTE 6. COMMITMENTS AND CONTINGENCIES Registration and Shareholder Rights The holders of Founder Shares, Private Placement Warrants, and securities that may be issued upon conversion of Working Capital Loans, if any, will be entitled to registration rights pursuant to a registration rights agreement dated as of July -up Underwriting Agreement The Company granted the underwriters a 45 -day -allotments -allotment The underwriters were paid a cash underwriting discount of $0.20 per unit, or $6.9 Risks and Uncertainties Management is continuing to evaluate the impact of the COVID -19

Derivative Warrant Liabilities

Derivative Warrant Liabilities	3 Months Ended	8 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Warrant Liabilities	Note 6 — Derivative Warrant Liabilities The Public Warrants will become exercisable at $11.50 per share on the later of (a) 30 days after the completion of a Business Combination or (b) 12 th The warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. If (x) the Company issues additional Class A ordinary shares or equity -linked The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the ordinary shares issuable upon exercise of the Private Placement Warrants, so long as they are held by the Sponsor or its permitted transferees, (i) will not be redeemable by the Company, (ii) may not (including the Class A ordinary shares issuable upon exercise of these warrants), subject to certain limited exceptions, be transferred, assigned or sold by the holders until 30 days after the completion of the initial Business Combination, (iii) may be exercised by the holders on a cashless basis and (iv) will be entitled to registration rights. If the Private Placement Warrants are held by holders other than the Sponsor or its permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by the holders on the same basis as the Public Warrants. Redemption of Warrants when the price per Class A ordinary share equals or exceeds $18.00. • • • • -trading In no event will the Company be required to net cash settle any Warrants. Redemption of Warrants when the price per Class A ordinary share equals or exceeds $10.00 • • • provided • -trading If the Company is unable to complete the Initial Business Combination within the combination period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. As of March	NOTE 7. DERIVATIVE WARRANT LIABILITIES As of December The Public Warrants will become exercisable at $11.50 per share on the later of (a) 30 days after the completion of a Business Combination or (b) 12 th Company will have failed to maintain an effective registration statement, exercise Warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Company’s Class A ordinary shares are at the time of any exercise of a Warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their Warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, the Company will use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. The Warrants have an exercise price of $11.50 per share, subject to adjustments, and will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. In addition, if (x) the Company issues additional Class A ordinary shares or equity -linked -trading The Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. If (x) the Company issues additional Class A ordinary shares or equity -linked The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the ordinary shares issuable upon exercise of the Private Placement Warrants, so long as they are held by the Sponsor or its permitted transferees, (i) will not be redeemable by the Company, (ii) may not (including the Class A ordinary shares issuable upon exercise of these Warrants), subject to certain limited exceptions, be transferred, assigned or sold by the holders until 30 days after the completion of the initial Business Combination, (iii) may be exercised by the holders on a cashless basis and (iv) will be entitled to registration rights. If the Private Placement Warrants are held by holders other than the Sponsor or its permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by the holders on the same basis as the Public Warrants. Redemption of Warrants for cash when the price per Class A ordinary share equals or exceeds $18.00: • • • • -trading The Company will not redeem the Warrants as described above unless a registration statement under the Securities Act covering the issuance of the Class A ordinary shares issuable upon exercise of the Warrants is then effective and a current prospectus relating to those Class A ordinary shares is available throughout the 30 -day In no event will the Company be required to net cash settle any Warrants. Redemption of Warrants for Class A ordinary shares when the price per Class A ordinary share equals or exceeds $10.00: • • • provided • -trading If the Company is unable to complete the Initial Business Combination within the combination period and the Company liquidates the funds held in the Trust Account, holders of Warrants will not receive any of such funds with respect to their Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the Warrants may expire worthless.

Shareholders' Equity

Shareholders' Equity	3 Months Ended	8 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Stockholders' Equity Note [Abstract]
SHAREHOLDERS’ EQUITY	Note 7 — Shareholders’ Equity Class A Ordinary Shares Class B Ordinary Shares -allotment -allotment Holders of the Class A ordinary shares and holders of the Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the Company’s shareholders, except as required by law or stock exchange rule; provided that only holders of the Class B ordinary shares have the right to appoint directors in any election held prior to or in connection with the completion of the initial Business Combination. The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of the Initial Business Combination on a one -for-one -linked -linked -linked -for-one Preference Shares	NOTE 8. SHAREHOLDERS’ EQUITY Class A Ordinary Shares — Class B Ordinary Shares — -allotment -allotment Holders of the Class A ordinary shares and holders of the Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the Company’s shareholders, except as required by law or stock exchange rule; provided that only holders of the Class B ordinary shares have the right to appoint directors in any election held prior to or in connection with the completion of the initial Business Combination. The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of the Initial Business Combination on a one -for-one -linked -linked -linked -for-one Preference Shares

Fair Value Measurements

Fair Value Measurements	3 Months Ended	8 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Fair Value Disclosures [Abstract]
Fair Value Measurements	Note 8 — Fair Value Measurements The following table presents information about the Company’s assets that are measured at fair value on a recurring basis as of March Fair Value Measured as of March 31, 2021 Level 1 Level 2 Level 3 Total Assets Investments held in Trust Account – U.S. Treasury Securities $ 345,258,401 $ — $ — $ 345,258,401 Liabilities: Warrant liabilities – public warrants 19,837,500 — — 19,837,500 Warrant liabilities – private warrants — — 11,303,000 11,303,000 Fair Value Measured as of December 31, 2020 Level 1 Level 2 Level 3 Total Assets Investments held in Trust Account – U.S. Treasury Securities $ 345,191,130 $ — $ — $ 345,191,130 Liabilities: Warrant liabilities – public warrants 18,112,500 — — 18,112,500 Warrant liabilities – private warrants — — 11,303,000 11,303,000 Transfers to/from Levels The fair value of warrants issued in connection with the Private Placement has been estimated using Black -Scholes -Scholes There is no change in the fair value of the Level 3 derivative warrant liabilities during the three months ended March The estimated fair value of the derivative warrant liabilities of the private warrants is determined using Level 3 inputs. Inherent in a Black -Scholes -price -free -free -coupon The following table provides quantitative information regarding Level 3 fair value measurements inputs: March 31, As of Exercise price $ 11.50 $ 11.50 Stock Price $ 9.94 $ 10.16 Term (in years) 5.50 5.50 Volatility 23.50 % 23.5 % Risk-free interest rate 1.00 % 0.5 % Dividend yield 0.00 % 0.00 %	NOTE 9. FAIR VALUE MEASURMENTS The following table presents information about the Company’s financial assets that are measured at fair value on a recurring basis as of December December 31, 2020 Description Quoted Significant Significant Assets: U. S. Treasury Securities $ 345,191,130 $ — $ — Liabilities: Derivative warrant liabilities – Public Warrants $ 18,112,500 $ — $ — Derivative warrant liabilities – Private Warrants $ — $ — $ 11,303,000 Transfers to/from Levels The fair value of Public Warrants, was calculated using a binomial / lattice model that assumes optimal exercise of the Company’s redemption option, including the make whole table, at the earliest possible date. The fair value of Private Warrants was calculated using the Black -Scholes The fair value of Public Warrants issued in connection with the Initial Public Offering have been measured based on the listed market price of such Warrants, a Level 1 measurement, since September The estimated fair value of the Private Placement Warrants, and the Public Warrants prior to being separately listed and traded, is determined using Level 3 inputs. Inherent Black -Scholes -price -free -free -coupon The following table provides quantitative information regarding Level 3 fair value measurements inputs at their measurement: Initial As of Volatility 23.5 % 23.5 % Stock price $ 9.72 $ 10.16 Expected life of the options to convert 5.5 5.5 Risk-free rate 0.4 % 0.5 % Dividend yield 0.0 % 0.0 % Transfers to/from Levels The change in the fair value of the derivative warrant liabilities measured with Level 3 inputs for the period from May Derivative warrant liabilities at May 6, 2020 (inception) $ — Issuance of Public and Private Warrants, Level 3 measurements 20,802,500 Transfer of Public Warrants to Level 1 (11,902,500 ) Change in fair value of derivative warrant liabilities, Level 3 2,403,000 Derivative warrant liabilities – Level 3, at December 31, 2020 $ 11,303,000

Subsequent Events

Subsequent Events	3 Months Ended	8 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Subsequent Events [Abstract]
Subsequent Events	Note 9 — Subsequent Events On April -owned There is no assurance that the Company’s plans to consummate its Initial Business Combination with Vicarious Surgical. Management has evaluated subsequent events to determine if events or transactions occurring through the date the financial statements were issued required potential adjustment to or disclosure in the financial statements and has concluded that all such events that would require recognition or disclosure have been recognized or disclosed.	NOTE 10. SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the balance sheet date through the date the financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.

Restatement of Previously Issue

Restatement of Previously Issued Financial Statements	8 Months Ended
	Dec. 31, 2020
Condensed Financial Information Disclosure [Abstract]
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS	NOTE 2. RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS In May 2021, the Audit Committee of the Company, in consultation with management, concluded that, because of a misapplication of the accounting guidance related to its public and private placement warrants to purchase Class A ordinary shares that the Company issued in July 2020 (the “Warrants”), the Company’s previously issued financial statements for the Affected Periods should no longer be relied upon. As such, the Company is restating its financial statements for the Affected Periods included in this Annual Report. On April Historically, the Warrants were reflected as a component of equity as opposed to liabilities on the balance sheets and the statements of operations did not include the subsequent non -cash -40 -40 -40 Impact of the Restatement The impact of the restatement on the balance sheets, statements of operations and statements of cash flows for the Affected Periods is presented below. The restatement had no impact on net cash flows from operating, investing or financing activities. As of December 31, 2020 As Previously Restatement As Restated Balance Sheet Total assets $ 346,421,401 $ — $ 346,421,401 Liabilities and shareholders’ equity Total current liabilities $ 126,220 $ — $ 126,220 Deferred legal fees — — Deferred underwriting commissions 12,075,000 — 12,075,000 Derivative warrant liabilities — 29,415,500 29,415,500 Total liabilities 12,201,220 29,415,500 41,616,720 Class A ordinary shares, $0.0001 par value; shares subject to possible redemption shareholders’ equity 329,220,171 (29,415,491 ) 299,804,680 Preference shares – $0.0001 par value — — — Class A ordinary shares – $0.0001 par value 161 291 452 Class B ordinary shares – $0.0001 par value 863 — 863 Additional paid-in-capital 5,160,164 9,301,230 14,461,394 Accumulated deficit (161,178 ) (9,301,230 ) (9,462,708 ) Total shareholders’ equity 5,000,010 (9 ) 5,000,001 Total liabilities and shareholders’ equity $ 346,421,401 $ — $ 346,421,401 Period From May 6, 2020 (Inception) As Previously Restatement As Restated Statement of Operations Loss from operations $ (352,308 ) $ — $ (352,308 ) Other (expense) income: Change in fair value of derivative warrant liabilities — (8,613,000 ) (8,613,000 ) Financing cost derivative warrant liabilities — (688,530 ) (688,530 ) Interest earned on investments held in Trust Account 191,130 — 191,130 Total other (expense) income 191,130 (9,301,530 ) (9,110,400 ) Net loss $ (161,178 ) $ (9,301,530 ) $ (9,462,708 ) Basic and Diluted weighted-average Class A ordinary shares outstanding 34,312,500 — 34,312,500 Basic and Diluted net loss per Class A share $ 0.01 — $ 0.01 Basic and Diluted weighted-average Class B ordinary shares outstanding 8,280,711 — 8,280,711 Basic and Diluted net loss per Class B share $ (0.04 ) $ (1.12 ) $ (1.17 ) Period From May 6, 2020 (Inception) As Previously Restatement As Restated Statement of Cash Flows Net loss $ (161,178 ) $ (9,301,530 ) $ (9,462,708 ) Change in fair value of derivative warrant liabilities — 8,613,000 8,613,000 Financing Costs – derivative warrant liabilities — 688,530 688,530 Net cash used in operating activities (427,301 ) — (427,301 ) Net cash used in investing activities (345,000,000 ) — (345,000,000 ) Net cash provided by financing activities 346,524,614 — 346,524,614 Net change in cash $ 1,097,313 $ — $ 1,097,313 In addition, the impact to the balance sheet dated July -K

Quarterly Financial Information

Quarterly Financial Information (Unaudited)	8 Months Ended
	Dec. 31, 2020
Quarterly Financial Information Disclosure [Abstract]
QUARTERLY FINANCIAL INFORMATION (UNAUDITED)	NOTE 11. QUARTERLY FINANCIAL INFORMATION (UNAUDITED) The following tables contain unaudited consolidated quarterly financial information for the quarterly period ended September -Q As of September 30, 2020 As Previously Restatement As Unaudited Condensed Balance Sheet Total assets $ 346,471,407 $ — $ 346,471,407 Liabilities and shareholders’ equity Total current liabilities $ 132,667 $ — $ 132,667 Deferred underwriting commissions 12,075,000 — 12,075,000 Derivative warrant liabilities — 22,388,000 22,388,000 Total liabilities 12,207,667 22,388,000 34,595,667 Class A ordinary shares, $0.0001 par value; shares subject to possible redemption shareholders’ equity 329,263,730 (22,388,000 ) 306,875,730 Preference shares – $0.0001 par value — — — Class A ordinary shares – $0.0001 par value 157 224 381 Class B ordinary shares – $0.0001 par value 863 — 863 Additional paid-in-capital 5,116,609 2,273,806 7,390,415 Accumulated deficit (117,619 ) (2,274,030 ) (2,391,649 ) Total shareholders’ equity 5,000,010 — 5,000,010 Total liabilities and shareholders’ equity $ 346,471,407 $ — $ 346,471,407 Three Months Ended As Previously Restatement As Unaudited Condensed Statement of Operations Loss from operations $ (181,964 ) $ — $ (181,964 ) Other (expense) income: Change in fair value of derivative warrant liabilities — (1,585,500 ) (1,585,500 ) Financing cost – derivative warrant liabilities — (688,530 ) (688,530 ) Interest earned on investments held in Trust Account 91,049 — 91,049 Total other (expense) income 91,049 (2,274,030 ) (2,182,981 ) Net loss $ (90,915 ) $ (2,274,030 ) $ (2,364,945 ) Basic and Diluted weighted-average Class A ordinary shares outstanding 34,085,526 34,085,526 Basic and Diluted net loss per Class A share $ — $ 0.00 Basic and Diluted weighted-average Class B ordinary shares outstanding 8,625,000 8,625,000 Basic and Diluted net loss per Class B share $ (0.02 ) $ (0.26 ) $ (0.28 ) Period From May 6, 2020 (Inception) As Previously Restatement As Unaudited Condensed Statement of Operations Loss from operations $ (208,668 ) $ — $ (208,668 ) Other (expense) income: Change in fair value of warrant liabilities — (1,585,500 ) (1,585,500 ) Financing costs — (688,530 ) (688,530 ) Interest earned on investments held in Trust Account 91,049 — 91,049 Total other (expense) income 91,049 (2,274,030 ) (2,182,981 ) Net loss $ (117,619 ) $ (2,274,030 ) $ (2,391,649 ) Basic and Diluted weighted-average Class A ordinary shares outstanding 34,085,526 — 34,085,526 Basic and Diluted net loss per Class A share $ 0.00 — $ 0.00 Basic and Diluted weighted-average Class B ordinary shares outstanding 8,625,000 — 8,625,000 Basic and Diluted net loss per Class B share $ (0.02 ) $ (0.26 ) $ (0.29 ) Period From May 6, 2020 (Inception) As Previously Restatement As Unaudited Condensed Statement of Cash Flows Net loss $ (117,619 ) $ (2,274,030 ) $ (2,391,649 ) Change in fair value of derivative warrant liabilities — 1,585,500 1,585,500 Financing Costs – derivative warrant liabilities — 688,530 688,530 Net cash used in operating activities (347,771 ) — (347,771 ) Net cash used in investing activities (345,000,000 ) — (345,000,000 ) Net cash provided by financing activities 346,524,614 — 346,524,614 Net change in cash $ 1,176,843 $ — $ 1,176,843

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	3 Months Ended	8 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed financial statements of the Company have been prepared in accordance with United States generally accepted accounting principles (“U.S. GAAP”) for interim financial information and Article 8 of Regulation S -X The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Company’s Annual Report on Form 10K/A filed with the SEC on May	Basis of presentation The accompanying financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC. As described in Note 2 — Restatement of Previously Issued Financial Statements and Note 11 — Quarterly Financial Information (unaudited), the Company’s financial statements for the period from May -K
Emerging Growth Company	Emerging Growth Company As an emerging growth company, the Company may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes -Oxley Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non -emerging opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. This may make comparison of the Company’s financial statement with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.	Emerging growth company As an emerging growth company, the Company may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes -Oxley Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non -emerging Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. This may make comparison of the Company’s financial statement with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liability. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.	Use of estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liability. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short -term	Cash and Cash Equivalents The Company considers all short -term
Investments Held in Trust Accounts	Investments Held in Trust Accounts The Company’s portfolio of investments is comprised solely of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities, or a combination thereof. The Company’s investments held in the Trust Accounts are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in gain on investment (net), dividends and interest held in Trust Account in the accompanying unaudited condensed statement of operations. The estimated fair values of investments held in the Trust Accounts are determined using available market information.	Investments Held in the Trust Account The Company’s portfolio of investments held in the Trust Account is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, investments in money market funds that invest in U.S. government securities, cash, or a combination thereof. The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in gain on Investments Held in Trust Account in the accompanying statement of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000, and investments held in Trust Accounts. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.	Concentrations of credit risk Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage of $250,000, and investments held in Trust Account. At December
Fair Value of Financial Instruments	Fair Value of Financial Instruments Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three -tier The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: • • • In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. As of March -term	Fair Value of Financial Instruments Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three -tier • • • In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. As of December -term The fair value of Public Warrants, was calculated using a binomial / lattice model that assumes optimal exercise of the Company’s redemption option, including the make whole table, at the earliest possible date. The fair value of Private Warrants was calculated using the Black -Scholes
Offering Costs Associated with the Initial Public Offering	Offering Costs Associated with the Initial Public Offering The Company complies with the requirements of the FASB ASC Topic 340 -10-S99-1 -in
Class A Ordinary Shares Subject to Possible Redemption	Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at March	Class A Ordinary Shares subject to possible redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Shares of Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Shares of conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, shares of Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at December
Income Taxes	Income Taxes FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of March penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of March The Company is considered an exempted Cayman Islands company and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the periods presented. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.	Income taxes ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more -likely-than-not The Company is considered an exempted Cayman Islands company and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the periods presented. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Net Income (Loss) per Ordinary Share	Net Income (Loss) per Ordinary Share The Company complies with accounting and disclosure requirements of ASC Topic 260, “Earnings Per Share.” Net income (loss) per ordinary share is computed by dividing net income (loss) by the weighted average number of ordinary shares outstanding during the period. The Company has not considered the effect of the warrants sold in the Initial Public Offering and Private Placement to purchase an aggregate of 26,150,000 -dilutive The Company’s statement of operations include a presentation of income per share for ordinary shares subject to redemption in a manner similar to the two -class	Net loss per ordinary share The Company complies with accounting and disclosure requirements of ASC Topic 260, “Earnings Per Share.” Net loss per ordinary share is computed by dividing net loss by the weighted average number of ordinary shares outstanding during the period. The Company has not considered the effect of the Warrants sold in the Initial Public Offering and Private Placement to purchase an aggregate of 26,150,000 -dilutive The Company’s statement of operations include a presentation of income per share for ordinary shares subject to redemption in a manner similar to the two -class
Derivative warrant liabilities	Derivative warrant liabilities The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued shares purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815 -15 -assessed The Company accounts for its 26,150,000 warrants issued in connection with its Initial Public Offering (17,250,000) and Private Placement (8,900,000) as derivative warrant liabilities in accordance with ASC 815 -40 -measurement -Scholes -Scholes	Derivative Warrant liabilities The Company does not use derivative instruments to hedge its exposures to cash flow, market or foreign currency risks. Management evaluates all of the Company’s financial instruments, including issued Warrants to purchase its Class A ordinary shares, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815 -15 -assessed The Company issued 17,250,000 Warrants to purchase Class A ordinary shares to investors in the Company’s Initial Public Offering and simultaneously issued 8,900,000 Private Placement Warrants. All of the Company’s outstanding Warrants are recognized as derivative liabilities in accordance with ASC 815 -40 -measurement -Scholes
Recent Adopted Accounting Standards	Recent Adopted Accounting Standards In August 2020, the FASB issued ASU No. 2020 -06 -20 -40 -06 -linked and it simplifies the diluted earnings per share calculation in certain areas. The Company adopted ASU 2020 -06
Recent Issued Accounting Standards	Recent Issued Accounting Standards The Company’s management does not believe that any recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the accompanying financial statement.	Recent accounting pronouncements In August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020 -06 Debt — debt with Conversion and Other Options (Subtopic 470 -20 ) and Derivatives and Hedging — Contracts in Entity’ Own Equity (Subt opic 815 -40 ): Accounting for Convertible Instruments and Contracts in an Entity’ Own Equity -06 -linked -06 The Company’s management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.
Offering costs		Offering costs Offering costs consist legal, accounting, underwriting fees and other costs incurred in connection with the formation and preparation for the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities are expensed as incurred, presented as non -operating

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended	8 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Fair Value Disclosures [Abstract]
Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]	Fair Value Measured as of March 31, 2021 Level 1 Level 2 Level 3 Total Assets Investments held in Trust Account – U.S. Treasury Securities $ 345,258,401 $ — $ — $ 345,258,401 Liabilities: Warrant liabilities – public warrants 19,837,500 — — 19,837,500 Warrant liabilities – private warrants — — 11,303,000 11,303,000 Fair Value Measured as of December 31, 2020 Level 1 Level 2 Level 3 Total Assets Investments held in Trust Account – U.S. Treasury Securities $ 345,191,130 $ — $ — $ 345,191,130 Liabilities: Warrant liabilities – public warrants 18,112,500 — — 18,112,500 Warrant liabilities – private warrants — — 11,303,000 11,303,000	Description Quoted Significant Significant Assets: U. S. Treasury Securities $ 345,191,130 $ — $ — Liabilities: Derivative warrant liabilities – Public Warrants $ 18,112,500 $ — $ — Derivative warrant liabilities – Private Warrants $ — $ — $ 11,303,000
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	March 31, As of Exercise price $ 11.50 $ 11.50 Stock Price $ 9.94 $ 10.16 Term (in years) 5.50 5.50 Volatility 23.50 % 23.5 % Risk-free interest rate 1.00 % 0.5 % Dividend yield 0.00 % 0.00 %	Initial As of Volatility 23.5 % 23.5 % Stock price $ 9.72 $ 10.16 Expected life of the options to convert 5.5 5.5 Risk-free rate 0.4 % 0.5 % Dividend yield 0.0 % 0.0 %
Fair Value, Liabilities Measured on Recurring and Nonrecurring Basis [Table Text Block]		Derivative warrant liabilities at May 6, 2020 (inception) $ — Issuance of Public and Private Warrants, Level 3 measurements 20,802,500 Transfer of Public Warrants to Level 1 (11,902,500 ) Change in fair value of derivative warrant liabilities, Level 3 2,403,000 Derivative warrant liabilities – Level 3, at December 31, 2020 $ 11,303,000

Restatement of Previously Iss_2

Restatement of Previously Issued Financial Statements (Tables)	8 Months Ended
	Dec. 31, 2020
Condensed Financial Information Disclosure [Abstract]
Schedule of restatement of balance sheets	As of December 31, 2020 As Previously Restatement As Restated Balance Sheet Total assets $ 346,421,401 $ — $ 346,421,401 Liabilities and shareholders’ equity Total current liabilities $ 126,220 $ — $ 126,220 Deferred legal fees — — Deferred underwriting commissions 12,075,000 — 12,075,000 Derivative warrant liabilities — 29,415,500 29,415,500 Total liabilities 12,201,220 29,415,500 41,616,720 Class A ordinary shares, $0.0001 par value; shares subject to possible redemption shareholders’ equity 329,220,171 (29,415,491 ) 299,804,680 Preference shares – $0.0001 par value — — — Class A ordinary shares – $0.0001 par value 161 291 452 Class B ordinary shares – $0.0001 par value 863 — 863 Additional paid-in-capital 5,160,164 9,301,230 14,461,394 Accumulated deficit (161,178 ) (9,301,230 ) (9,462,708 ) Total shareholders’ equity 5,000,010 (9 ) 5,000,001 Total liabilities and shareholders’ equity $ 346,421,401 $ — $ 346,421,401
Schedule of restatement of operations	Period From May 6, 2020 (Inception) As Previously Restatement As Restated Statement of Operations Loss from operations $ (352,308 ) $ — $ (352,308 ) Other (expense) income: Change in fair value of derivative warrant liabilities — (8,613,000 ) (8,613,000 ) Financing cost derivative warrant liabilities — (688,530 ) (688,530 ) Interest earned on investments held in Trust Account 191,130 — 191,130 Total other (expense) income 191,130 (9,301,530 ) (9,110,400 ) Net loss $ (161,178 ) $ (9,301,530 ) $ (9,462,708 ) Basic and Diluted weighted-average Class A ordinary shares outstanding 34,312,500 — 34,312,500 Basic and Diluted net loss per Class A share $ 0.01 — $ 0.01 Basic and Diluted weighted-average Class B ordinary shares outstanding 8,280,711 — 8,280,711 Basic and Diluted net loss per Class B share $ (0.04 ) $ (1.12 ) $ (1.17 )
Schedule of restatement of cash flows	Period From May 6, 2020 (Inception) As Previously Restatement As Restated Statement of Cash Flows Net loss $ (161,178 ) $ (9,301,530 ) $ (9,462,708 ) Change in fair value of derivative warrant liabilities — 8,613,000 8,613,000 Financing Costs – derivative warrant liabilities — 688,530 688,530 Net cash used in operating activities (427,301 ) — (427,301 ) Net cash used in investing activities (345,000,000 ) — (345,000,000 ) Net cash provided by financing activities 346,524,614 — 346,524,614 Net change in cash $ 1,097,313 $ — $ 1,097,313

Quarterly Financial Informati_2

Quarterly Financial Information (Unaudited) (Tables)	8 Months Ended
	Dec. 31, 2020
Quarterly Financial Information Disclosure [Abstract]
Condensed Balance Sheet [Table Text Block]	As of September 30, 2020 As Previously Restatement As Unaudited Condensed Balance Sheet Total assets $ 346,471,407 $ — $ 346,471,407 Liabilities and shareholders’ equity Total current liabilities $ 132,667 $ — $ 132,667 Deferred underwriting commissions 12,075,000 — 12,075,000 Derivative warrant liabilities — 22,388,000 22,388,000 Total liabilities 12,207,667 22,388,000 34,595,667 Class A ordinary shares, $0.0001 par value; shares subject to possible redemption shareholders’ equity 329,263,730 (22,388,000 ) 306,875,730 Preference shares – $0.0001 par value — — — Class A ordinary shares – $0.0001 par value 157 224 381 Class B ordinary shares – $0.0001 par value 863 — 863 Additional paid-in-capital 5,116,609 2,273,806 7,390,415 Accumulated deficit (117,619 ) (2,274,030 ) (2,391,649 ) Total shareholders’ equity 5,000,010 — 5,000,010 Total liabilities and shareholders’ equity $ 346,471,407 $ — $ 346,471,407
Condensed Income Statement [Table Text Block]	Three Months Ended As Previously Restatement As Unaudited Condensed Statement of Operations Loss from operations $ (181,964 ) $ — $ (181,964 ) Other (expense) income: Change in fair value of derivative warrant liabilities — (1,585,500 ) (1,585,500 ) Financing cost – derivative warrant liabilities — (688,530 ) (688,530 ) Interest earned on investments held in Trust Account 91,049 — 91,049 Total other (expense) income 91,049 (2,274,030 ) (2,182,981 ) Net loss $ (90,915 ) $ (2,274,030 ) $ (2,364,945 ) Basic and Diluted weighted-average Class A ordinary shares outstanding 34,085,526 34,085,526 Basic and Diluted net loss per Class A share $ — $ 0.00 Basic and Diluted weighted-average Class B ordinary shares outstanding 8,625,000 8,625,000 Basic and Diluted net loss per Class B share $ (0.02 ) $ (0.26 ) $ (0.28 ) Period From May 6, 2020 (Inception) As Previously Restatement As Unaudited Condensed Statement of Operations Loss from operations $ (208,668 ) $ — $ (208,668 ) Other (expense) income: Change in fair value of warrant liabilities — (1,585,500 ) (1,585,500 ) Financing costs — (688,530 ) (688,530 ) Interest earned on investments held in Trust Account 91,049 — 91,049 Total other (expense) income 91,049 (2,274,030 ) (2,182,981 ) Net loss $ (117,619 ) $ (2,274,030 ) $ (2,391,649 ) Basic and Diluted weighted-average Class A ordinary shares outstanding 34,085,526 — 34,085,526 Basic and Diluted net loss per Class A share $ 0.00 — $ 0.00 Basic and Diluted weighted-average Class B ordinary shares outstanding 8,625,000 — 8,625,000 Basic and Diluted net loss per Class B share $ (0.02 ) $ (0.26 ) $ (0.29 )
Condensed Cash Flow Statement [Table Text Block]	Period From May 6, 2020 (Inception) As Previously Restatement As Unaudited Condensed Statement of Cash Flows Net loss $ (117,619 ) $ (2,274,030 ) $ (2,391,649 ) Change in fair value of derivative warrant liabilities — 1,585,500 1,585,500 Financing Costs – derivative warrant liabilities — 688,530 688,530 Net cash used in operating activities (347,771 ) — (347,771 ) Net cash used in investing activities (345,000,000 ) — (345,000,000 ) Net cash provided by financing activities 346,524,614 — 346,524,614 Net change in cash $ 1,176,843 $ — $ 1,176,843

Description of Organization a_2

Description of Organization and Business Operations (Details) - USD ($)	1 Months Ended		3 Months Ended	8 Months Ended
	Jul. 24, 2020	Jul. 17, 2020	Mar. 31, 2021	Dec. 31, 2020
Description of Organization and Business Operations (Details) [Line Items]
Share price (in Dollars per share)			$ 9.94	$ 10.16
Generating gross proceeds	$ 900,000
Business combination agreement, description			In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.00 per share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or business combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the trust account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable. This liability will not apply with respect to any claims by a third party who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) or to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”).	In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.00 per share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or business combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the trust account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable. This liability will not apply with respect to any claims by a third party who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) or to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”).
Underwriting fees	19,500,000
Deferred underwriting fees	12,100,000
Offering costs	19,500,000
Business combination acquires, percentage			20.00%	20.00%
Business combination acquire, description			The Company will provide its holders (the “Public Shareholders”) of its Class A ordinary shares, par value $0.0001, sold in the Initial Public Offering, with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a general meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per Public Share). The per-share amount to be distributed to Public Shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 5). These Public Shares were classified as temporary equity upon the completion of the Initial Public Offering in accordance with the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 and the approval of an ordinary resolution.	The Company will provide its holders (the “Public Shareholders”) of its Class A ordinary shares, par value $0.0001, sold in the Initial Public Offering, with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a general meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per Public Share). The per-share amount to be distributed to Public Shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 5). These Public Shares were classified as temporary equity upon the completion of the Initial Public Offering in accordance with the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 and the approval of an ordinary resolution.
Business combination redeem			100.00%	100.00%
Dissolution expenses Interest			$ 100,000	$ 100,000
Operating bank account			1,000,000	1,100,000
Working capital			422,000	1,100,000
Payment for liquidity needs			25,000	25,000
Note issued to sponsor			$ 127,000	127,000
Business combination net tangible assets				$ 5,000,001
Percentage of redemption of outstanding public shares				100.00%
Initial Public Offering [Member]
Description of Organization and Business Operations (Details) [Line Items]
Number of proposed public offering units (in Shares)		30,000,000
Share price (in Dollars per share)		$ 10	$ 10	$ 10
Generating gross proceeds		$ 300,000,000	$ 345,000,000	$ 345,000,000
Business combination agreement, description		Each Unit consists of one Class A ordinary share (the “Public Shares”) of the Company, par value $0.0001, and one-half of one redeemable warrant (the “Public Warrants”) of the Company, with each whole warrant entitled to purchase one Class A Ordinary Share for $11.50 per share, subject to adjustment.
Offering costs				$ 700,000
Fair market value, percentage			80.00%	80.00%
Business combination acquires, percentage			50.00%	50.00%
Over-Allotment Option [Member]
Description of Organization and Business Operations (Details) [Line Items]
Generating gross proceeds	$ 45,000,000
Number of additional units purchased (in Shares)	4,500,000	45,000,000
Private Placement [Member]
Description of Organization and Business Operations (Details) [Line Items]
Number of proposed public offering units (in Shares)		8,000,000
Share price (in Dollars per share)		$ 1	$ 1	$ 1
Generating gross proceeds			$ 8,000,000	$ 8,000,000
Number of warrants consummated (in Shares)			8,000,000	8,000,000
Purchase price per unit (in Dollars per share)			$ 11.50	$ 11.50
Offering costs			$ 16,000
Number of additional warrants sale to sponsor (in Shares)	900,000

Basic of Presentation and Sum_2

Basic of Presentation and Summary of Significant Accounting Policies (Details) - USD ($)	3 Months Ended	8 Months Ended
	Mar. 31, 2021	Dec. 31, 2020	Jul. 24, 2020
Basic of Presentation and Summary of Significant Accounting Policies (Details) [Line Items]
Federal depository insurance	$ 250,000
Purchase an aggregate share of common stock (in Shares)	26,150,000
Net loss per share basic and diluted amount	$ 3,200,000
Issuance of warrant (in Shares)	26,150,000
Federal depository insurance coverage		$ 250,000
Total offering costs			$ 19,500,000
Shareholders’ equity		$ 18,900,000
Warrants to purchase, description		The Company issued 17,250,000 Warrants to purchase Class A ordinary shares to investors in the Company’s Initial Public Offering and simultaneously issued 8,900,000 Private Placement Warrants.
Description of net loss per ordinary share		Net loss per share, basic and diluted for Class A ordinary shares is calculated by dividing the investment income earned on the Trust Account of approximately $191,000 for the period from May 6 (inception), 2020 through December 31, 2020 by the weighted average number of shares of Class A ordinary shares outstanding for the period. Net loss per share, basic and diluted for Class B ordinary shares is calculated by dividing the net loss of approximately $9.5 million, less income attributable to Class A ordinary shares, by the weighted average number of shares of Class B ordinary shares outstanding for the period.
Trust Account [Member]
Basic of Presentation and Summary of Significant Accounting Policies (Details) [Line Items]
Investment income	$ 67,000
IPO [Member]
Basic of Presentation and Summary of Significant Accounting Policies (Details) [Line Items]
Derivative warrant liabilities	17,250,000
Total offering costs		$ 700,000
Private Placement [Member]
Basic of Presentation and Summary of Significant Accounting Policies (Details) [Line Items]
Derivative warrant liabilities	8,900,000
Total offering costs	$ 16,000
Class A Ordinary Shares [Member]
Basic of Presentation and Summary of Significant Accounting Policies (Details) [Line Items]
Ordinary shares subject to possible redemption (in Shares)	29,662,115	29,980,468
Purchase an aggregate share of common stock (in Shares)		26,150,000

Initial Public Offering (Detail

Initial Public Offering (Details) - USD ($)	1 Months Ended		3 Months Ended	8 Months Ended
	Jul. 24, 2020	Jul. 17, 2020	Mar. 31, 2021	Dec. 31, 2020
Initial Public Offering (Details) [Line Items]
Sale of share per unit (in Dollars per share)			$ 9.94	$ 10.16
Total offering costs	$ 19,500,000
Deferred underwriting fees	12,100,000	$ 12,100,000
Initial public offering unit, description			Each Unit consists of one Class A ordinary share, par value $0.0001 and one-half of one redeemable warrant.	Each Unit consists of one Class A ordinary share, par value $0.0001 and one-half of one redeemable Warrant.
Initial Public Offering [Member]
Initial Public Offering (Details) [Line Items]
Number of initial public offering units (in Shares)		30,000,000
Sale of share per unit (in Dollars per share)		$ 10	$ 10	$ 10
Gross proceeds		$ 300,000,000
Total offering costs				$ 700,000
Over-Allotment Option [Member]
Initial Public Offering (Details) [Line Items]
Gross proceeds	$ 4,500,000	$ 4,500,000
Number of additional units purchased (in Shares)	4,500,000	45,000,000
Class A Ordinary Shares [Member]
Initial Public Offering (Details) [Line Items]
Sale of share per unit (in Dollars per share)		$ 11.50		$ 11.50
Ordinary share, par value (in Dollars per share)	$ 0.0001		$ 0.0001	0.0001
Price per share (in Dollars per share)				$ 11.50

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)	Jul. 14, 2020	May 14, 2020	Jul. 24, 2020	Jul. 17, 2020	Jun. 25, 2020	Mar. 31, 2021	Dec. 31, 2020
Related Party Transactions (Details) [Line Items]
Price per warrant (in Dollars per share)						$ 11.50	$ 11.50
Sale of share per unit (in Dollars per share)						$ 9.94	$ 10.16
Offering costs			$ 19,500,000
Sponsor loan amount		$ 300,000
Borrowing amount		127,000
Working capital loans						$ 1,500,000	$ 1,500,000
Office space						10,000
Administrative fees						$ 30,000
Administrative fees							$ 55,000
Warrant [Member]
Related Party Transactions (Details) [Line Items]
Price per warrant (in Dollars per share)							$ 1
Robert Kirby [Member]
Related Party Transactions (Details) [Line Items]
Number of founder shares (in Shares)					15,000
Michael Kives [Member]
Related Party Transactions (Details) [Line Items]
Number of founder shares (in Shares)					25,000
Fred Langhammer [Member]
Related Party Transactions (Details) [Line Items]
Number of founder shares (in Shares)					25,000
Terry Lundgren [Member]
Related Party Transactions (Details) [Line Items]
Number of founder shares (in Shares)					25,000
Founder Shares [Member]
Related Party Transactions (Details) [Line Items]
Cash paid		$ 25,000
Ordinary share, par value (in Dollars per share)		$ 0.003
Number of founder shares (in Shares)					7,097,500
Founder shares, description	the Company effected a share capitalization of 1,437,500 Founder Shares resulting in 8,625,000 Class B ordinary shares outstanding, of which the Sponsor now holds 8,535,000 Founder Shares. All shares and the associated amounts have been retroactively restated to reflect the share capitalization. Of the 8,625,000 Founder Shares outstanding, up to 1,125,000 Founder Shares were subject to forfeiture to the extent that the over-allotment option was not exercised in full by the underwriters, so that the Founder Shares will represent 20.0% of the Company’s issued and outstanding shares after the Initial Public Offering. The underwriters exercised their over-allotment option in full on July 24, 2020. As a result, these shares were no longer subject to forfeiture.					Notwithstanding the foregoing, if (1) the closing price of Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the initial Business Combination or (2) if the Company consummates a transaction after the initial Business Combination which results in the Company’s shareholders having the right to exchange their shares for cash, securities or other property, the Founder Shares will be released from the lock-up.	(1) the closing price of Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the initial Business Combination or (2) if the Company consummates a transaction after the initial Business Combination which results in the Company’s shareholders having the right to exchange their shares for cash, securities or other property, the Founder Shares will be released from the lock-up.
Private Placement Warrants [Member]
Related Party Transactions (Details) [Line Items]
Number of proposed public offering units (in Shares)				8,000,000
Price per warrant (in Dollars per share)						$ 1
Sale of share per unit (in Dollars per share)				$ 1		$ 1	$ 1
Gross proceeds			$ 900,000	$ 8,000,000
Offering costs						$ 16,000
Number of additional warrants sale to sponsor (in Shares)			900,000
Sponsor [Member]
Related Party Transactions (Details) [Line Items]
Administrative fees							$ 10,000
Class B Ordinary Shares [Member]
Related Party Transactions (Details) [Line Items]
Ordinary share, par value (in Dollars per share)						$ 0.0001	$ 0.0001
Class B Ordinary Shares [Member] | Founder Shares [Member]
Related Party Transactions (Details) [Line Items]
Ordinary share, par value (in Dollars per share)		$ 0.0001
Shares issued (in Shares)		7,187,500
Class A Ordinary Shares [Member]
Related Party Transactions (Details) [Line Items]
Ordinary share, par value (in Dollars per share)			$ 0.0001			0.0001	0.0001
Price per warrant (in Dollars per share)				$ 11.50		$ 11.50
Sale of share per unit (in Dollars per share)				$ 11.50			$ 11.50

Commitments and Contingencies (

Commitments and Contingencies (Details) - shares	3 Months Ended	8 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Commitments and Contingencies (Details) [Line Items]
Underwriting agreement, description	The underwriters were paid a cash underwriting discount of $0.20 per unit, or $6.9 million in the aggregate, paid upon the closing of the Initial Public Offering. In addition, $0.35 per unit, or approximately $12.1 million in the aggregate, will be payable to the underwriters for deferred underwriting commissions.	The underwriters were paid a cash underwriting discount of $0.20 per unit, or $6.9 million in the aggregate, paid upon the closing of the Initial Public Offering. In addition, $0.35 per unit, or approximately $12.1 million in the aggregate, will be payable to the underwriters for deferred underwriting commissions.
Over-Allotment Option [Member]
Commitments and Contingencies (Details) [Line Items]
Purchase of additional units	4,500,000	4,500,000

Derivative Warrant Liabilities

Derivative Warrant Liabilities (Details) - $ / shares	3 Months Ended	8 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Derivative Warrant Liabilities (Details) [Line Items]
Warrant exercisable	$ 11.50	$ 11.50
Warrant expire term	5 years	5 years
Business combination, description	If (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the initial shareholders or their affiliates, without taking into account any Founder Shares held by the initial shareholders or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of our initial business combination (net of redemptions), and (z) the volume weighted average trading price of the Class A ordinary shares during the 10 trading day period starting on the trading day prior to the day on which the Company consummates the initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the Warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger prices described below under “Redemption of Warrants when the price per Class A ordinary share equals or exceeds $18.00” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price described below under “Redemption of Warrants when the price per Class A ordinary share equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price.	If (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the initial shareholders or their affiliates, without taking into account any Founder Shares held by the initial shareholders or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of our initial business combination (net of redemptions), and (z) the volume weighted average trading price of the Class A ordinary shares during the 10 trading day period starting on the trading day prior to the day on which the Company consummates the initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the Warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger prices described below under “Redemption of Warrants when the price per Class A ordinary share equals or exceeds $18.00” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price described below under “Redemption of Warrants when the price per Class A ordinary share equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price.
Warrants, description		if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the Initial Shareholders or their affiliates, without taking into account any Founder Shares held by the Initial Shareholders or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of Class A ordinary shares during the 10-trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, then the exercise price of the Warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price (and the $10.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price See “— Redemption of Warrants for cash when the price per class A ordinary share equals or exceeds $18.00” and “— Redemption of Warrants for Class A ordinary shares when the price per class A ordinary share equals or exceeds $10.00” as described below).
Warrant outstanding	26,150,000
Warrant [Member]
Derivative Warrant Liabilities (Details) [Line Items]
Warrant exercisable		$ 1
Sale of stock price		$ 11.50
Public warrants [Member]
Derivative Warrant Liabilities (Details) [Line Items]
shares issued		15,000,000
Private warrants [Member]
Derivative Warrant Liabilities (Details) [Line Items]
shares issued		8,000,000
Exercise price $18.00 [Member]
Derivative Warrant Liabilities (Details) [Line Items]
Warrants, description	Redemption of Warrants when the price per Class A ordinary share equals or exceeds $18.00. The Company may call the Public Warrants for redemption: • in whole and not in part; • at a price of $0.01 per warrant; • upon a minimum of 30 days’ prior written notice of redemption; and • if, and only if, the last reported sale price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.	Redemption of Warrants for cash when the price per Class A ordinary share equals or exceeds $18.00: Once the Warrants become exercisable, the Company may call the outstanding Warrants for redemption (except as described herein with respect to the Private Placement Warrants): • in whole and not in part; • at a price of $0.01 per Warrant; • upon a minimum of 30 days’ prior written notice of redemption; and • if, and only if, the last reported sales price of Class A ordinary shares equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.
Exercise price $10.00 [Member]
Derivative Warrant Liabilities (Details) [Line Items]
Warrants, description	Redemption of Warrants when the price per Class A ordinary share equals or exceeds $10.00. The Company may also redeem the outstanding Public Warrants once they become exercisable: • in whole and not in part; • at a price of $0.10 per warrant; • upon a minimum of 30 days’ prior written notice of redemption; provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares based on the redemption date and the “fair market value” of the Company’s Class A ordinary shares; and • if, and only if, the last reported sale price of the Class A ordinary shares equals or exceeds $10.00 per share (as adjusted) for any 20 trading days within a 30-trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders.	Redemption of Warrants for Class A ordinary shares when the price per Class A ordinary share equals or exceeds $10.00: The Company may also redeem the outstanding Public Warrants once they become exercisable: • in whole and not in part; • at $0.10 per Warrant; • upon a minimum of 30 days’ prior written notice of redemption; provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares based on the redemption date and the “fair market value” of the Company’s Class A ordinary shares; and • if, and only if, the last reported sale price of the Class A ordinary shares equals or exceeds $10.00 per share (as adjusted) for any 20 trading days within a 30-trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders.

Shareholders' Equity (Details)

Shareholders' Equity (Details) - $ / shares	Jul. 14, 2020	Mar. 31, 2021	Dec. 31, 2020	Jul. 24, 2020	May 14, 2020
Shareholders' Equity (Details) [Line Items]
Initial shareholder percentage		20.00%
Percentage of class A ordinary shares outstanding		20.00%	20.00%
Preferred shares, shares authorized		1,000,000	1,000,000
Preferred shares, shares issued		0	0
Preferred shares, shares outstanding		0	0
Founder Shares [Member]
Shareholders' Equity (Details) [Line Items]
Ordinary shares, par value (in Dollars per share)					$ 0.003
Class A Ordinary Shares [Member]
Shareholders' Equity (Details) [Line Items]
Ordinary shares, shares authorized		200,000,000	200,000,000
Ordinary shares, par value (in Dollars per share)		$ 0.0001	$ 0.0001	$ 0.0001
Ordinary shares, shares issued		4,837,885	4,519,532
Ordinary shares subject to possible Redemption		29,662,115	29,980,468
Ordinary shares, shares outstanding		4,837,885	4,519,532
Class B Ordinary Shares [Member]
Shareholders' Equity (Details) [Line Items]
Ordinary shares, shares authorized		20,000,000	20,000,000
Ordinary shares, par value (in Dollars per share)		$ 0.0001	$ 0.0001
Ordinary shares, shares issued		8,625,000	8,625,000
Shares issued					7,187,500
Ordinary shares, shares outstanding	8,625,000	8,625,000	8,625,000
Aggregate of ordinary shares	8,625,000
Subject to forfeiture shares	1,125,000
Ordinary shares voting right, description			Holders are entitled to one vote for each share of Class B ordinary shares.
Sale of stock, description	the Company effected a share capitalization of 1,437,500 Founder Shares resulting in 8,625,000 Class B ordinary shares outstanding. All shares and the associated amounts have been retroactively restated to reflect the share capitalization. Of the 8,625,000 Class B ordinary shares, an aggregate of up to 1,125,000 shares were subject to forfeiture to the Company for no consideration to the extent that the underwriters’ over-allotment option is not exercised in full or in part, so that the initial shareholders would collectively own 20% of the Company’s issued and outstanding ordinary shares after the Initial Public Offering. The underwriters exercised their over-allotment option in full on July 24, 2020. As a result, these shares were no longer subject to forfeiture.
Class B Ordinary Shares [Member] | Founder Shares [Member]
Shareholders' Equity (Details) [Line Items]
Ordinary shares, par value (in Dollars per share)					$ 0.0001
share capitalization	1,437,500

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($) $ in Millions	Mar. 31, 2021	Dec. 31, 2020
Fair Value Disclosures [Abstract]
Change in fair value of derivative warrant liabilities	$ 1.7	$ 8.6

Fair Value Measurements (Deta_2

Fair Value Measurements (Details) - Schedule of assets that are measured at fair value on a recurring basis - USD ($)	Mar. 31, 2021	Dec. 31, 2020
Assets
Investments held in Trust Account – U.S. Treasury Securities	$ 345,258,401	$ 345,191,130
Liabilities:
Warrant liabilities – public warrants	19,837,500	18,112,500
Warrant liabilities – private warrants	11,303,000	11,303,000
Level 1 [Member]
Assets
Investments held in Trust Account – U.S. Treasury Securities	345,258,401	345,191,130
Liabilities:
Warrant liabilities – public warrants	19,837,500	18,112,500
Warrant liabilities – private warrants
Level 2 [Member]
Assets
Investments held in Trust Account – U.S. Treasury Securities
Liabilities:
Warrant liabilities – public warrants
Warrant liabilities – private warrants
Level 3 [Member]
Assets
Investments held in Trust Account – U.S. Treasury Securities
Liabilities:
Warrant liabilities – public warrants
Warrant liabilities – private warrants	$ 11,303,000	$ 11,303,000

Fair Value Measurements (Deta_3

Fair Value Measurements (Details) - Schedule of quantitative information regarding Level 3 fair value measurements - $ / shares	3 Months Ended	8 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Schedule of quantitative information regarding Level 3 fair value measurements [Abstract]
Exercise price (in Dollars per share)	$ 11.50	$ 11.50
Stock Price (in Dollars per share)	$ 9.94	$ 10.16
Term (in years)	5 years 6 months	5 years 6 months
Volatility	23.50%	23.50%
Risk-free interest rate	1.00%	0.50%
Dividend yield	0.00%	0.00%

Restatement of Previously Iss_3

Restatement of Previously Issued Financial Statements (Details) $ in Millions	1 Months Ended
	Jul. 17, 2020USD ($)
Condensed Financial Information Disclosure [Abstract]
Derivative warrant liabilities	$ 18.4

Restatement of Previously Iss_4

Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement of balance sheets - USD ($)	Dec. 31, 2020	Sep. 30, 2020
As Previously Reported [Member]
Balance Sheet
Total assets	$ 346,421,401	$ 346,471,407
Total current liabilities	126,220	132,667
Deferred legal fees
Deferred underwriting commissions	12,075,000	12,075,000
Derivative warrant liabilities
Total liabilities	12,201,220	12,207,667
Class A ordinary shares, $0.0001 par value; shares subject to possible redemption shareholders’ equity	329,220,171	329,263,730
Preference shares – $0.0001 par value
Class A ordinary shares – $0.0001 par value	161	157
Class B ordinary shares – $0.0001 par value	863	863
Additional paid-in-capital	5,160,164	5,116,609
Accumulated deficit	(161,178)	(117,619)
Total shareholders’ equity	5,000,010	5,000,010
Total liabilities and shareholders’ equity	346,421,401	346,471,407
Restatement Adjustment [Member]
Balance Sheet
Total assets
Total current liabilities
Deferred underwriting commissions
Derivative warrant liabilities	29,415,500
Total liabilities	29,415,500	22,388,000
Class A ordinary shares, $0.0001 par value; shares subject to possible redemption shareholders’ equity	(29,415,491)	(22,388,000)
Preference shares – $0.0001 par value
Class A ordinary shares – $0.0001 par value	291	224
Class B ordinary shares – $0.0001 par value
Additional paid-in-capital	9,301,230	2,273,806
Accumulated deficit	(9,301,230)	(2,274,030)
Total shareholders’ equity	(9)
Total liabilities and shareholders’ equity
As Restated [Member]
Balance Sheet
Total assets	346,421,401	346,471,407
Total current liabilities	126,220	132,667
Deferred legal fees
Deferred underwriting commissions	12,075,000	12,075,000
Derivative warrant liabilities	29,415,500
Total liabilities	41,616,720	34,595,667
Class A ordinary shares, $0.0001 par value; shares subject to possible redemption shareholders’ equity	299,804,680	306,875,730
Preference shares – $0.0001 par value
Class A ordinary shares – $0.0001 par value	452	381
Class B ordinary shares – $0.0001 par value	863	863
Additional paid-in-capital	14,461,394	7,390,415
Accumulated deficit	(9,462,708)	(2,391,649)
Total shareholders’ equity	5,000,001	5,000,010
Total liabilities and shareholders’ equity	$ 346,421,401	$ 346,471,407

Restatement of Previously Iss_5

Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement of balance sheets (Parentheticals)	Dec. 31, 2020$ / shares
As Previously Reported [Member]
Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement of balance sheets (Parentheticals) [Line Items]
Ordinary shares, subject to possible redemption, par value	$ 0.0001
Preference shares, par value	0.0001
As Previously Reported [Member] | Class A Ordinary Shares [Member]
Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement of balance sheets (Parentheticals) [Line Items]
Ordinary shares, par value	0.0001
As Previously Reported [Member] | Class B Ordinary Shares [Member]
Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement of balance sheets (Parentheticals) [Line Items]
Ordinary shares, par value	0.0001
Restatement Adjustment [Member]
Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement of balance sheets (Parentheticals) [Line Items]
Ordinary shares, subject to possible redemption, par value	0.0001
Preference shares, par value	0.0001
Restatement Adjustment [Member] | Class A Ordinary Shares [Member]
Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement of balance sheets (Parentheticals) [Line Items]
Ordinary shares, par value	0.0001
Restatement Adjustment [Member] | Class B Ordinary Shares [Member]
Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement of balance sheets (Parentheticals) [Line Items]
Ordinary shares, par value	0.0001
As Restated [Member]
Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement of balance sheets (Parentheticals) [Line Items]
Ordinary shares, subject to possible redemption, par value	0.0001
Preference shares, par value	0.0001
As Restated [Member] | Class A Ordinary Shares [Member]
Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement of balance sheets (Parentheticals) [Line Items]
Ordinary shares, par value	0.0001
As Restated [Member] | Class B Ordinary Shares [Member]
Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement of balance sheets (Parentheticals) [Line Items]
Ordinary shares, par value	$ 0.0001

Restatement of Previously Iss_6

Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement of operations - USD ($)	3 Months Ended		5 Months Ended	8 Months Ended
	Mar. 31, 2021	Sep. 30, 2020	Sep. 30, 2020	Dec. 31, 2020
Statement of Operations
Loss from operations	$ (1,525,798)	$ (181,964)	$ (208,668)	$ (352,308)
Other (expense) income:
Change in fair value of derivative warrant liabilities		(1,585,500)		(8,613,000)
Financing cost derivative warrant liabilities		(688,530)		(688,530)
Interest earned on investments held in Trust Account		91,049	91,049	191,130
Total other (expense) income		(2,182,981)	(2,182,981)	(9,110,400)
Net loss	(3,183,527)	$ (2,364,945)	$ (2,391,649)	(9,462,708)
Class A Ordinary Shares [Member]
Other (expense) income:
Net loss
Basic and Diluted weighted-average shares outstanding (in Shares)	34,500,000	34,085,526	34,085,526	34,312,500
Basic and Diluted net loss per share (in Dollars per share)	$ 0	$ 0	$ 0	$ 0.01
Class B Ordinary Shares [Member]
Other (expense) income:
Net loss
Basic and Diluted weighted-average shares outstanding (in Shares)	8,625,000	8,625,000	8,625,000	8,280,711
Basic and Diluted net loss per share (in Dollars per share)	$ (0.38)	$ (0.28)	$ (0.29)	$ (1.17)
As Previously Reported [Member]
Statement of Operations
Loss from operations		$ (181,964)	$ (208,668)	$ (352,308)
Other (expense) income:
Change in fair value of derivative warrant liabilities
Financing cost derivative warrant liabilities
Interest earned on investments held in Trust Account		91,049	91,049	191,130
Total other (expense) income		91,049	91,049	191,130
Net loss		$ (90,915)	$ (117,619)	$ (161,178)
As Previously Reported [Member] | Class A Ordinary Shares [Member]
Other (expense) income:
Basic and Diluted weighted-average shares outstanding (in Shares)		34,085,526	34,085,526	34,312,500
Basic and Diluted net loss per share (in Dollars per share)			$ 0	$ 0.01
As Previously Reported [Member] | Class B Ordinary Shares [Member]
Other (expense) income:
Basic and Diluted weighted-average shares outstanding (in Shares)		8,625,000	8,625,000	8,280,711
Basic and Diluted net loss per share (in Dollars per share)		$ (0.02)	$ (0.02)	$ (0.04)
Restatement Adjustment [Member]
Statement of Operations
Loss from operations
Other (expense) income:
Change in fair value of derivative warrant liabilities		(1,585,500)		(8,613,000)
Financing cost derivative warrant liabilities		(688,530)		(688,530)
Interest earned on investments held in Trust Account
Total other (expense) income		(2,274,030)	(2,274,030)	(9,301,530)
Net loss		$ (2,274,030)	$ (2,274,030)	$ (9,301,530)
Restatement Adjustment [Member] | Class A Ordinary Shares [Member]
Other (expense) income:
Basic and Diluted weighted-average shares outstanding (in Shares)
Basic and Diluted net loss per share (in Dollars per share)
Restatement Adjustment [Member] | Class B Ordinary Shares [Member]
Other (expense) income:
Basic and Diluted weighted-average shares outstanding (in Shares)
Basic and Diluted net loss per share (in Dollars per share)		$ (0.26)	$ (0.26)	$ (1.12)

Restatement of Previously Iss_7

Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement of cash flows - USD ($)	3 Months Ended	5 Months Ended	8 Months Ended
	Mar. 31, 2021	Sep. 30, 2020	Dec. 31, 2020
Statement of Cash Flows
Net loss		$ (2,391,649)	$ (9,462,708)
Change in fair value of derivative warrant liabilities	$ 1,725,000	1,585,500	8,613,000
Financing Costs – derivative warrant liabilities			688,530
Net cash used in operating activities	(69,349)	(347,771)	(427,301)
Net cash used in investing activities		(345,000,000)	(345,000,000)
Net cash provided by financing activities		346,524,614	346,524,614
Net change in cash	$ (69,349)	1,176,843	1,097,313
As Previously Reported [Member]
Statement of Cash Flows
Net loss		(117,619)	(161,178)
Change in fair value of derivative warrant liabilities
Financing Costs – derivative warrant liabilities
Net cash used in operating activities		(347,771)	(427,301)
Net cash used in investing activities		(345,000,000)	(345,000,000)
Net cash provided by financing activities		346,524,614	346,524,614
Net change in cash		1,176,843	1,097,313
Restatement Adjustment [Member]
Statement of Cash Flows
Net loss		(2,274,030)	(9,301,530)
Change in fair value of derivative warrant liabilities		1,585,500	8,613,000
Financing Costs – derivative warrant liabilities			688,530
Net cash used in operating activities
Net cash used in investing activities
Net cash provided by financing activities
Net change in cash

Fair Value Measurements (Deta_4

Fair Value Measurements (Details) - Schedule of assets that are measured at fair value on a recurring basis - USD ($)	Mar. 31, 2021	Dec. 31, 2020
Level 1 [Member]
Assets:
U. S. Treasury Securities	$ 345,258,401	$ 345,191,130
Liabilities:
Derivative warrant liabilities – Public Warrants	19,837,500	18,112,500
Derivative warrant liabilities – Private Warrants
Level 2 [Member]
Assets:
U. S. Treasury Securities
Liabilities:
Derivative warrant liabilities – Public Warrants
Derivative warrant liabilities – Private Warrants
Level 3 [Member]
Assets:
U. S. Treasury Securities
Liabilities:
Derivative warrant liabilities – Public Warrants
Derivative warrant liabilities – Private Warrants	$ 11,303,000	$ 11,303,000

Fair Value Measurements (Deta_5

Fair Value Measurements (Details) - Schedule of quantitative information regarding Level 3 fair value measurements - $ / shares	3 Months Ended	8 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Volatility	23.50%	23.50%
Stock price (in Dollars per share)	$ 9.94	$ 10.16
Expected life of the options to convert		5 years 6 months
Risk-free rate	1.00%	0.50%
Dividend yield	0.00%	0.00%
Initial Measurement [Member]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Volatility		23.50%
Stock price (in Dollars per share)		$ 9.72
Expected life of the options to convert		5 years 6 months
Risk-free rate		0.40%
Dividend yield		0.00%

Fair Value Measurements (Deta_6

Fair Value Measurements (Details) - Schedule of change in the fair value of the derivative warrant liabilities measured with Level 3 inputs	8 Months Ended
	Dec. 31, 2020USD ($)
Schedule of change in the fair value of the derivative warrant liabilities measured with Level 3 inputs [Abstract]
Derivative warrant liabilities
Derivative warrant liabilities – Level 3	11,303,000
Issuance of Public and Private Warrants, Level 3 measurements	20,802,500
Transfer of Public Warrants to Level 1	(11,902,500)
Change in fair value of derivative warrant liabilities, Level 3	$ 2,403,000

Quarterly Financial Informati_3

Quarterly Financial Information (Unaudited) (Details) - Schedule of unaudited condensed balance sheet - USD ($)	Dec. 31, 2020	Sep. 30, 2020
As Previously Reported [Member]
Condensed Balance Sheet Statements, Captions [Line Items]
Total assets	$ 346,421,401	$ 346,471,407
Total current liabilities	126,220	132,667
Deferred underwriting commissions	12,075,000	12,075,000
Derivative warrant liabilities
Total liabilities	12,201,220	12,207,667
Class A ordinary shares, $0.0001 par value; shares subject to possible redemption shareholders’ equity	329,220,171	329,263,730
Preference shares – $0.0001 par value
Class A ordinary shares – $0.0001 par value	161	157
Class B ordinary shares – $0.0001 par value	863	863
Additional paid-in-capital	5,160,164	5,116,609
Accumulated deficit	(161,178)	(117,619)
Total shareholders’ equity	5,000,010	5,000,010
Total liabilities and shareholders’ equity	346,421,401	346,471,407
Restatement Adjustment [Member]
Condensed Balance Sheet Statements, Captions [Line Items]
Total assets
Total current liabilities
Deferred underwriting commissions
Derivative warrant liabilities		22,388,000
Total liabilities	29,415,500	22,388,000
Class A ordinary shares, $0.0001 par value; shares subject to possible redemption shareholders’ equity	(29,415,491)	(22,388,000)
Preference shares – $0.0001 par value
Class A ordinary shares – $0.0001 par value	291	224
Class B ordinary shares – $0.0001 par value
Additional paid-in-capital	9,301,230	2,273,806
Accumulated deficit	(9,301,230)	(2,274,030)
Total shareholders’ equity	(9)
Total liabilities and shareholders’ equity
As Restated [Member]
Condensed Balance Sheet Statements, Captions [Line Items]
Total assets	346,421,401	346,471,407
Total current liabilities	126,220	132,667
Deferred underwriting commissions	12,075,000	12,075,000
Derivative warrant liabilities		22,388,000
Total liabilities	41,616,720	34,595,667
Class A ordinary shares, $0.0001 par value; shares subject to possible redemption shareholders’ equity	299,804,680	306,875,730
Preference shares – $0.0001 par value
Class A ordinary shares – $0.0001 par value	452	381
Class B ordinary shares – $0.0001 par value	863	863
Additional paid-in-capital	14,461,394	7,390,415
Accumulated deficit	(9,462,708)	(2,391,649)
Total shareholders’ equity	5,000,001	5,000,010
Total liabilities and shareholders’ equity	$ 346,421,401	$ 346,471,407

Quarterly Financial Informati_4

Quarterly Financial Information (Unaudited) (Details) - Schedule of unaudited condensed statement of operations - USD ($)	3 Months Ended		5 Months Ended	8 Months Ended
	Mar. 31, 2021	Sep. 30, 2020	Sep. 30, 2020	Dec. 31, 2020
Condensed Income Statements, Captions [Line Items]
Loss from operations	$ (1,525,798)	$ (181,964)	$ (208,668)	$ (352,308)
Change in fair value of warrant liabilities	(1,725,000)		(1,585,500)	(8,613,000)
Financing costs			(688,530)
Change in fair value of derivative warrant liabilities		(1,585,500)		(8,613,000)
Financing cost – derivative warrant liabilities		(688,530)		(688,530)
Interest earned on investments held in Trust Account		91,049	91,049	191,130
Total other (expense) income		(2,182,981)	(2,182,981)	(9,110,400)
Net loss	(3,183,527)	$ (2,364,945)	$ (2,391,649)	(9,462,708)
Class A Ordinary Shares [Member]
Condensed Income Statements, Captions [Line Items]
Net loss
Basic and Diluted weighted-average shares outstanding (in Shares)	34,500,000	34,085,526	34,085,526	34,312,500
Basic and Diluted net loss pershare (in Dollars per share)	$ 0	$ 0	$ 0	$ 0.01
Class B Ordinary Shares [Member]
Condensed Income Statements, Captions [Line Items]
Net loss
Basic and Diluted weighted-average shares outstanding (in Shares)	8,625,000	8,625,000	8,625,000	8,280,711
Basic and Diluted net loss pershare (in Dollars per share)	$ (0.38)	$ (0.28)	$ (0.29)	$ (1.17)
As Previously Reported [Member]
Condensed Income Statements, Captions [Line Items]
Loss from operations		$ (181,964)	$ (208,668)	$ (352,308)
Change in fair value of warrant liabilities
Financing costs
Change in fair value of derivative warrant liabilities
Financing cost – derivative warrant liabilities
Interest earned on investments held in Trust Account		91,049	91,049	191,130
Total other (expense) income		91,049	91,049	191,130
Net loss		$ (90,915)	$ (117,619)	$ (161,178)
As Previously Reported [Member] | Class A Ordinary Shares [Member]
Condensed Income Statements, Captions [Line Items]
Basic and Diluted weighted-average shares outstanding (in Shares)		34,085,526	34,085,526	34,312,500
Basic and Diluted net loss pershare (in Dollars per share)			$ 0	$ 0.01
As Previously Reported [Member] | Class B Ordinary Shares [Member]
Condensed Income Statements, Captions [Line Items]
Basic and Diluted weighted-average shares outstanding (in Shares)		8,625,000	8,625,000	8,280,711
Basic and Diluted net loss pershare (in Dollars per share)		$ (0.02)	$ (0.02)	$ (0.04)
Restatement Adjustment [[Member]
Condensed Income Statements, Captions [Line Items]
Loss from operations
Change in fair value of warrant liabilities			(1,585,500)	(8,613,000)
Financing costs			(688,530)
Change in fair value of derivative warrant liabilities		(1,585,500)		(8,613,000)
Financing cost – derivative warrant liabilities		(688,530)		(688,530)
Interest earned on investments held in Trust Account
Total other (expense) income		(2,274,030)	(2,274,030)	(9,301,530)
Net loss		$ (2,274,030)	$ (2,274,030)	$ (9,301,530)
Restatement Adjustment [[Member] | Class A Ordinary Shares [Member]
Condensed Income Statements, Captions [Line Items]
Basic and Diluted weighted-average shares outstanding (in Shares)
Basic and Diluted net loss pershare (in Dollars per share)
Restatement Adjustment [[Member] | Class B Ordinary Shares [Member]
Condensed Income Statements, Captions [Line Items]
Basic and Diluted weighted-average shares outstanding (in Shares)
Basic and Diluted net loss pershare (in Dollars per share)		$ (0.26)	$ (0.26)	$ (1.12)

Quarterly Financial Informati_5

Quarterly Financial Information (Unaudited) (Details) - Schedule of unaudited condensed statement of cash flows - USD ($)	3 Months Ended	5 Months Ended	8 Months Ended
	Mar. 31, 2021	Sep. 30, 2020	Dec. 31, 2020
Condensed Cash Flow Statements, Captions [Line Items]
Net loss		$ (2,391,649)	$ (9,462,708)
Change in fair value of derivative warrant liabilities	$ 1,725,000	1,585,500	8,613,000
Financing Costs – derivative warrant liabilities		688,530	688,530
Net cash used in operating activities	(69,349)	(347,771)	(427,301)
Net cash used in investing activities		(345,000,000)	(345,000,000)
Net cash provided by financing activities		346,524,614	346,524,614
Net change in cash	$ (69,349)	1,176,843	1,097,313
As Previously Reported [Member]
Condensed Cash Flow Statements, Captions [Line Items]
Net loss		(117,619)	(161,178)
Change in fair value of derivative warrant liabilities
Financing Costs – derivative warrant liabilities
Net cash used in operating activities		(347,771)	(427,301)
Net cash used in investing activities		(345,000,000)	(345,000,000)
Net cash provided by financing activities		346,524,614	346,524,614
Net change in cash		1,176,843	1,097,313
Restatement Adjustment [Member]
Condensed Cash Flow Statements, Captions [Line Items]
Net loss		(2,274,030)	(9,301,530)
Change in fair value of derivative warrant liabilities		1,585,500	8,613,000
Financing Costs – derivative warrant liabilities		688,530
Net cash used in operating activities
Net cash used in investing activities
Net cash provided by financing activities
Net change in cash